Schlieren ZH – Pregnolia has secured 2.2 million Swiss francs in a financing round. The spin-off from the Swiss Federal Institute of Technology in Zurich has developed a device that can detect potential premature births.
Pregnolia AG, which specializes in the diagnosis of premature births, has Announcement successfully completed a financing round of 2.2 million Swiss francs on LinkedIn. The company intends to expand its measuring device for detecting premature birth risks into a diagnostic system and gain access to the US market, as detailed in a press release. Pregnolia has developed a measuring device that offers reliable detection of premature birth risks. A probe measures the firmness of the cervix. If this is too soft, the doctor can initiate therapeutic measures in good time.
Sabrina Badir, CEO of Pregnolia, recognized early on that the stiffness of the cervix is an extremely reliable indicator of a possible premature birth, according to the start-up's press release. "A soft cervix correlates with a premature birth. This fact has now been confirmed by several ongoing studies. Two of them were presented at this year's international symposium on spontaneous preterm birth in Holland," Badir is quoted as saying.
The start-up, which was founded as a spin-off from the Swiss Federal Institute of Technology in Zurich(ETH) at , is now working on developing this device into a premature birth diagnosis system that immediately shows doctors how high the risk of a pregnant woman suffering a spontaneous premature birth is. To this end, Pregnolia is building up a broad database of cervical stiffness values from normal pregnant women and pregnant women with premature labor or traditional risks in collaboration with specialists in Germany, the UK, the Netherlands and Italy.
The fresh capital will be used to finance the costs of ongoing clinical trials and data processing, as well as to prepare for the approval of the Pregnolia diagnostic system for the US market. ce/gba